期刊文献+

巨噬细胞抑制因子-1在胃癌中的作用 被引量:1

Role of macrophage inhibitory cytokine-1 in the development and progression of gastric cancer
下载PDF
导出
摘要 巨噬细胞抑制因子-1(macrophage inhibitory gytokine-1,MIC-1)是人转化生长因子β(transforming growth factor-β,TGF-β)超家族中的一个重要分支成员,在胃癌等多种肿瘤有过度表达.大量研究表明,MIC-1在胃癌早期通过诱导凋亡和抑制过度增生表现抑癌生物学活性,但近期有报道,在胃癌进展期因为内环境等的变化,MIC-1具有促癌作用,其机制包括:抑制连环蛋白cateninδ1基因的表达;上调uPA系统增强胃癌肿瘤细胞侵袭性;诱导ErbB2受体酪氨酸激酶在人体胃癌细胞等过度表达.胃癌组织过度表达MIC-1和uPA提示预后不良,故可以作为判断胃癌预后的指标. Macrophage inhibitory cytokine-1(MIC-1) is a divergent member of human transforming growth factor β(TGF-β) superfamily, which is overexpressed in a variety of human cancers, including gastric cancer. Numerous studies have shown that MIC-1 exerts tumor-suppressing activity through inducing apoptosis and inhibiting excessive proliferation in early gastric cancer. However, recent reports show that MIC-1 may contribute to the malignant progression of gastric cancer because of changes in internal environment in advanced gastric cancer. The mechanisms involved include: inhibiting the expression of catenin 61 gene, upregulating the urokinase plasminogen activator (uPA) system to enhance invasiveness of gastric cancer cells, and inducing overexpression of ErbB2 receptor tyrosine kinase in human gastric cancer cells. The overexpression of MIC-1 and uPA in gastric cancer cells indicates a poor prognosis. Therefore, MIC-1 and uPA can be used as indicators to predict the prognosis of gastric cancer.
机构地区 延安大学医学院
出处 《世界华人消化杂志》 CAS 北大核心 2009年第22期2272-2276,共5页 World Chinese Journal of Digestology
关键词 巨噬细胞抑制因子-1 胃癌 预后 Macrophage inhibitory cytokine-1 Gastric cancer Prognosis
  • 相关文献

参考文献30

  • 1Baek SJ, Kim JS, Moore SM, Lee SH, Martinez J, Eling TE. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Mol Pharmacol 2005; 67: 356-364.
  • 2Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH, Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, Choi I, Lee JH. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Cancer Res 2003; 63:4648-4655.
  • 3Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM, Breit SN. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A 1997; 94:11514-11519.
  • 4Fairlie WD, Moore AG, Bauskin AR, Russell PK, Zhang HP, Breit SN. MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol 1999; 65:2-5.
  • 5Lawton LN, Bonaldo MF, Jelenc PC, Qiu L, Baumes SA, Marcelino RA, de Jesus GM, Wellington S, Knowles JA, Warburton D, Brown S, Soares MB. Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta. Gene 1997; 203:17-26.
  • 6Fairlie WD, Zhang HP, Wu WM, Pankhurst SL, Bauskin AR, Russell PK, Brown PK, Breit SN. The propeptide of the transforming growth factor- beta superfamily member, macrophage inhibitory cytokine-1 (MIC-1), is a multifunctional domain that can facilitate protein folding and secretion. J Biol Chem 2001; 276:16911-16918.
  • 7Moore AG, Brown DA, Fairlie WD, Bauskin AR, Brown PK, Munier ML, Russell PK, Salamonsen LA, Wallace EM, Breit SN. The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J Clin Endocrinol Metab 2000; 85:4781-4788.
  • 8Park JY, Park KH, Bang S, Kim MH, Koh SS, Song SY. Expression of nonsteroidal anti-inflammatory drug-actirated gene-1 (NAG-1) inversely correlates with tumor progression in gastric adenomas and carcinomas. J Cancer Res Clin Oncol 2008; 134: 1029-1035.
  • 9管华琴,黄智铭,吴金明,吴建胜,陈向荣.巨噬细胞抑制因子-1 mRNA在胃癌及癌前病变黏膜组织中的表达及其临床意义[J].中华消化杂志,2008,28(6):405-407. 被引量:3
  • 10Baek KE, Yoon SR, Kim JT, Kim KS, Kang SH, Yang Y, Lim JS, Choi I, Nam MS, Yoon M, Lee HG. Upregulation and secretion of macrophage inhibitory cytokine-1 (MIC-1) in gastric cancers. Clin Chim Acta 2009; 401:128-133.

二级参考文献71

共引文献31

同被引文献22

  • 1郑佳,黄智铭.结直肠癌患者血清MIC-1的表达及意义[J].山东医药,2006,46(31):7-8. 被引量:1
  • 2王志宇,杨渤彦,窦征岳,韩强,贾琳,毕雪冰,程魏.MIC-1、VEGF和P53蛋白表达与直肠癌临床病理及预后的关系[J].中国癌症杂志,2007,17(8):607-609. 被引量:6
  • 3Bauskin AR, Bootcov MR, Valenzuela SM, et al. MIC-1 a novel macrephage inhibitory cytokine 1, is a divergent member of the TGF beta superfamily [ J ]. Proc Natl Acad Sci U S A, 1997,94 (21) :11514-11519.
  • 4Fairlie WD, Moore AG, Bauskin AR,et al. MIC-1 is a novel TGF-β Superfamily Cytokine associated with macrophage activation [ J ]. Leukocyte Biol, 1999,65 ( 1 ) :2-5.
  • 5Welsh JB, Sapinoso LM, Kern SG, et al. Large scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum[ J]. Proe Natl Acad Sci U S A,2003,100(6) :3410-3415.
  • 6Brown DA,Ward RL, Buckhaults P, et al. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma [ J ]. Clin Cancer Res, 2003,9 ( 7 ) : 2642-2650.
  • 7Graichen R,Liu D, Sun Y, et al. Autocrine human growth hormone inhibits placental transforming growth factor betagene transcription to prevent apoptosis and allow cell cycle progression of human mam- mary carcinoma ceils [ J ]. Biol Chem,2002,277 (29) :26662-26672.
  • 8Huh SJ, Chung CY, Sharma A, et al. Macrophage inhibitory cyto- kine-1 regulates melanoma vascular development[ J]. Am J Pathol, 2010,176(6) :2948-2957.
  • 9Kim KK, Lee JJ, Yang Y, et al. Macrophage inhibitory cytokine-I activities AKT and ERK1/2 via the transactivation of ErBb2 in human brest and gastric cancer cells[ J]. Carcinogenesis,2008,29 (4) :704-712.
  • 10Liu T, Bauskin AR, Zaunders J. Macrophage inhibitory cytokine-1 reduces cell adhesion and induces apoptosis in prostate cancer cells [ J]. Cancer Res ,2003,63 ( 16 ) :5034-5040.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部